Lovastatin

Product NDC: 10544-235
11-digit product format: 105440235
Labeler code: 10544
Product ID: 10544-235_0f88a46a-8488-3f5b-e054-00144ff88e88
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lovastatin
Dosage form: TABLET
Route: ORAL
Labeler: Blenheim Pharmacal, Inc.
Application: ANDA075991
Marketing category: ANDA
Marketing start: 2013-10-09
Marketing end: 0000-00-00
Substance: LOVASTATIN
Active strength: 10 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	10544-235		I	Inactivated by FDA		2026-08-03
excluded package	package	10544-235	10544-235-90	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	10544-235-90	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	10544-235-90	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	10544-235-90	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	10544-235-90	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	10544-235-90	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	10544-235-90	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	10544-235-90	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	10544-235-90	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	10544-235-90	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	10544-235-90	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	10544-235-90	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	10544-235-90	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	10544-235-90	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	10544-235-90	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	10544-235-90	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	10544-235-90	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	10544-235-90	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	10544-235-90	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	10544-235-90	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	10544-235-90	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	10544-235-90	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	10544-235-90	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075991-001	LOVASTATIN	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05
A075991-002	LOVASTATIN	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05
A075991-003	LOVASTATIN	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075991-001	AB
A075991-002	AB
A075991-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-002	LOVASTATIN	20MG	TABLET / ORAL	AB		2002-06-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-003	LOVASTATIN	40MG	TABLET / ORAL	AB	RS	2002-06-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075991-001	LOVASTATIN	10MG	TABLET / ORAL	AB		2002-06-05	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075991-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075991-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075991-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075991-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075991-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075991-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075991-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075991-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075991-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075991-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075991-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075991-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075991-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075991-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075991-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075991-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075991-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
dc9a5fb6-14e2-1cc8-a567-a781fd1f0212	Product name	1	20140508
f1ae760e-e8ec-b0b4-fb1b-2db7c49fcec5	Product name	1	20140508
fecc3d5d-ff9a-60ad-1a3a-6cb9b21df758	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
10544-235-90	2020-01-31	C162847	48780-1	9d75b9cf-d616-f424-e053-dadaa90a57ce	Lovastatin Tablet USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10544-235-90	Lovastatin	90 in 1 BOTTLE	TABLET	90		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10544-235-90	EA - Each	10544-235	d06ceef0-0541-4f60-aef6-d1bdb31f8c45	1	2015-04-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
LOVASTATIN	ACTIVE INGREDIENT	9LHU78OQFD	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
LOVASTATIN	ACTIVE MOIETY	9LHU78OQFD	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
POLOXAMER 188	INACTIVE INGREDIENT	LQA7B6G8JG	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10544-235	LOVASTATIN TABLET [BLENHEIM PHARMACAL, INC.]	1	Legacy NDC, 1 package rows	20150223_0f88a46a-8487-3f5b-e054-00144ff88e88.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 28 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lovastatin	LOVASTATIN	REMEDYREPACK INC.	9438d8a0-ca5b-4676-aab9-d0241ccff6c9	2026-07-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Preferred Pharmaceuticals Inc.	56680dfa-abe6-4587-b222-364315fd78f4	2026-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Preferred Pharmaceuticals, Inc.	ea4df37b-21e9-4dc3-83af-1be1b50bfdc9	2026-06-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	7fd9d5c7-8025-4049-8b5b-ae3d22db507f	2026-03-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Northwind Health Company, LLC	db47ddae-c574-427f-e053-2a95a90aae48	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	A-S Medication Solutions	dd7a223e-7fc5-4eb0-9bd7-2f9a2d6b4173	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	A-S Medication Solutions	bfb889a4-5751-4706-9fa7-f48672c1bc08	2025-10-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	220a9b3c-c583-49e3-8bf0-d0c97dc9b829	2025-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	PD-Rx Pharmaceuticals, Inc.	c37206ae-52f1-4192-9ab9-3044247cf58d	2025-03-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	PD-Rx Pharmaceuticals, Inc.	ac86821f-d741-4ab1-bd03-ce8797dd4f34	2025-03-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	PD-Rx Pharmaceuticals, Inc.	70e2bf86-4a78-4dfb-b6b1-8eb95f63684d	2025-03-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	PD-Rx Pharmaceuticals, Inc.	eea93a4b-f804-4b9c-aabf-e906f03c1e80	2025-02-28	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Boswell Pharmacy Services LLC d/b/a BPS Wholesale	2eff3e5e-8746-048e-e063-6294a90a38c4	2025-02-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Carlsbad Technology, Inc.	0a680e13-0356-4e08-a7fe-78b96ba51b9d	2025-01-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	c871a6a7-67a4-4ac1-b102-3f1604625c7d	2024-09-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	NuCare Pharmaceuticals, Inc.	415c2698-7787-49f8-e054-00144ff88e88	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	NuCare Pharmaceuticals, Inc.	4444573e-9df1-01e6-e054-00144ff8d46c	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	8d8199ca-df39-4eb8-a905-dee3ab7e2973	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	5684ceb8-a5b2-4fb4-92be-14aabcea3871	2024-08-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991
Lovastatin	LOVASTATIN	Bryant Ranch Prepack	ad905651-6e3a-4140-aa37-d91e5f37c0f0	2024-08-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075991 application number: ANDA075991

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9LHU78OQFD	LOVASTATIN	75330-75-5	LOVASTATIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197903	lovastatin 10 MG Oral Tablet	PSN	0f88a46a-8487-3f5b-e054-00144ff88e88	1
197904	lovastatin 20 MG Oral Tablet	PSN	0f88a46a-8487-3f5b-e054-00144ff88e88	1
197905	lovastatin 40 MG Oral Tablet	PSN	0f88a46a-8487-3f5b-e054-00144ff88e88	1
197903	lovastatin 10 MG Oral Tablet	SCD	0f88a46a-8487-3f5b-e054-00144ff88e88	1
197904	lovastatin 20 MG Oral Tablet	SCD	0f88a46a-8487-3f5b-e054-00144ff88e88	1
197905	lovastatin 40 MG Oral Tablet	SCD	0f88a46a-8487-3f5b-e054-00144ff88e88	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
10544-235-90	10544023590	90 in 1 BOTTLE	Historical